| Jennifer J Ceccardi, CNM | |
|
1622 E Turkeyfoot Lake Rd, #301, Akron, OH 44312-5277 | |
| (330) 344-8565 | |
| (330) 896-7085 |
| Full Name | Jennifer J Ceccardi |
|---|---|
| Gender | Female |
| Speciality | Certified Nurse Midwife (cnm) |
| Experience | 21 Years |
| Location | 1622 E Turkeyfoot Lake Rd, Akron, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851336812 | NPI | - | NPPES |
| 2551671 | Other | OH | PARTNERS PHYSICIAN GROUP MEDICAID GROUP # |
| 9338635 | Other | OH | PARTNERS PHYSICIAN GROUP MEDICARE GROUP # |
| 1841239274 | Other | OH | PARTNERS PHYSICIAN GROUP TYPE 2 NPI # |
| 2567217 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | NM-07497 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cleveland Clinic | Cleveland, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cleveland Clinic Foundation | 1850203555 | 5690 |
News Archive
Emisphere Technologies, Inc. announced study results in which twice-daily oral salmon calcitonin using Emisphere's proprietary Eligen® Drug Delivery Technology significantly suppressed markers of cartilage and bone degradation versus placebo in men and women with osteoarthritis, the most common form of arthritis.
BioSpace and BioMed Central are announcing the launch of the BioMed Central Career Network today, a new online community for life science professionals seeking quality recruitment, job opportunities and industry news.
The lowly and simple roundworm may be the ideal laboratory model to learn more about the complex processes involved in repairing wounds and could eventually allow scientists to improve the body's response to healing skin wounds, a serious problem in diabetics and the elderly.
Dr. E. Premkumar Reddy from Temple University School of Medicine and colleagues, in a study examining the effects of Plk1 inhibitor ON01910 on tumor growth in several animal models have found that a small molecule inhibitor of polo-like kinase1 (Plk1) could lead to a new avenue for targeted cancer therapy.
These reports have emerged from a Daily Telegraph investigation. Australian Medical Association vice president, GP and former Pharmaceutical Benefits Advisory Committee member Dr Steve Hambleton said the resons for these trends may include the increasing population of the aged, newer medicines as well as a rise in chronic lifestyle ailments like diabetes and high blood pressure.
› Verified 3 days ago
| Entity Name | The Cleveland Clinic Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679525919 PECOS PAC ID: 1850203555 Enrollment ID: O20031103000049 |
News Archive
Emisphere Technologies, Inc. announced study results in which twice-daily oral salmon calcitonin using Emisphere's proprietary Eligen® Drug Delivery Technology significantly suppressed markers of cartilage and bone degradation versus placebo in men and women with osteoarthritis, the most common form of arthritis.
BioSpace and BioMed Central are announcing the launch of the BioMed Central Career Network today, a new online community for life science professionals seeking quality recruitment, job opportunities and industry news.
The lowly and simple roundworm may be the ideal laboratory model to learn more about the complex processes involved in repairing wounds and could eventually allow scientists to improve the body's response to healing skin wounds, a serious problem in diabetics and the elderly.
Dr. E. Premkumar Reddy from Temple University School of Medicine and colleagues, in a study examining the effects of Plk1 inhibitor ON01910 on tumor growth in several animal models have found that a small molecule inhibitor of polo-like kinase1 (Plk1) could lead to a new avenue for targeted cancer therapy.
These reports have emerged from a Daily Telegraph investigation. Australian Medical Association vice president, GP and former Pharmaceutical Benefits Advisory Committee member Dr Steve Hambleton said the resons for these trends may include the increasing population of the aged, newer medicines as well as a rise in chronic lifestyle ailments like diabetes and high blood pressure.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer J Ceccardi, CNM 1622 E Turkeyfoot Lake Rd, #301, Akron, OH 44312-5277 Ph: (330) 344-8565 | Jennifer J Ceccardi, CNM 1622 E Turkeyfoot Lake Rd, #301, Akron, OH 44312-5277 Ph: (330) 344-8565 |
News Archive
Emisphere Technologies, Inc. announced study results in which twice-daily oral salmon calcitonin using Emisphere's proprietary Eligen® Drug Delivery Technology significantly suppressed markers of cartilage and bone degradation versus placebo in men and women with osteoarthritis, the most common form of arthritis.
BioSpace and BioMed Central are announcing the launch of the BioMed Central Career Network today, a new online community for life science professionals seeking quality recruitment, job opportunities and industry news.
The lowly and simple roundworm may be the ideal laboratory model to learn more about the complex processes involved in repairing wounds and could eventually allow scientists to improve the body's response to healing skin wounds, a serious problem in diabetics and the elderly.
Dr. E. Premkumar Reddy from Temple University School of Medicine and colleagues, in a study examining the effects of Plk1 inhibitor ON01910 on tumor growth in several animal models have found that a small molecule inhibitor of polo-like kinase1 (Plk1) could lead to a new avenue for targeted cancer therapy.
These reports have emerged from a Daily Telegraph investigation. Australian Medical Association vice president, GP and former Pharmaceutical Benefits Advisory Committee member Dr Steve Hambleton said the resons for these trends may include the increasing population of the aged, newer medicines as well as a rise in chronic lifestyle ailments like diabetes and high blood pressure.
› Verified 3 days ago
Elaine R Bishop, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 1 Park West Blvd, Suite 200, Akron, OH 44320 Phone: 330-869-9777 Fax: 330-865-6011 | |
Nadia Podojil, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 1 Park West Blvd, Suite 200, Akron, OH 44320 Phone: 330-869-9777 Fax: 330-865-6011 | |
Lisa L Warner, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 1 Park West Blvd, Suite 200, Akron, OH 44320 Phone: 330-869-9777 Fax: 330-869-0052 | |
Shana Ruth Goldstein-ptahia, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 51 Park West Blvd Ste 200, Akron, OH 44320 Phone: 234-312-6367 | |
Mrs. Teresa Marie Edwards, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 1 Park West Blvd, Suite 200, Akron, OH 44320 Phone: 330-869-9777 Fax: 330-869-0052 | |
Miss Britney Rose Crislip, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 51 Park West Blvd Ste 200, Akron, OH 44320 Phone: 234-312-6367 | |
Alice W Gordon, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 1 Park West Blvd, Suite 200, Akron, OH 44320 Phone: 330-869-9777 Fax: 330-869-0052 |